Literature DB >> 10943677

Epinephrine, but not dexamethasone, induces apoptosis in retinal pigment epithelium cells in vitro: possible implications on the pathogenesis of central serous chorioretinopathy.

S A Sibayan1, K Kobuch, D Spiegel, E Eckert, R Leser, J Monzer, V P Gabel.   

Abstract

BACKGROUND: The pathogenesis of central serous chorioretinopathy is poorly understood. It is believed to be due to dysfunction of the retinal pigment epithelium and/or choroid and has been associated with elevated levels of epinephrine and administration of corticosteroids. Epinephrine and corticosteroids have previously been shown to induce apoptosis (programmed cell death) in various types of cells. The objective of this study was to investigate whether these agents can induce apoptosis in cultured retinal pigment epithelium cells. This may help elucidate the pathogenesis of central serous chorioretinopathy.
METHODS: Third-passage porcine retinal pigment epithelium cells were grown to confluence and incubated for 1-7 days in culture medium containing epinephrine (10(2)-10(9) pg/ml) or a corticosteroid, dexamethasone (4-4x10(4) ng/ml). The cultures were evaluated for apoptosis by phase-contrast microscopy and in situ terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling.
RESULTS: Epinephrine (7x10(7)-10(9) pg/ml) induced apoptosis in a dose- and time-dependent manner. Exposure to lower concentrations of epinephrine (10(2)-6x10(7) pg/ml) and all tested levels of dexamethasone did not result in apoptosis.
CONCLUSION: Retinal pigment epithelium cells may undergo apoptosis following exposure to elevated levels of epinephrine. These findings suggest a possible pathophysiologic mechanism for the development of central serous chorioretinopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943677     DOI: 10.1007/pl00007893

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

Review 2.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

3.  [Intraocular injections of bevacizumab in rare indications--two cases].

Authors:  T Wecke; C Knop; W Schreiber; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

4.  A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®).

Authors:  Erdem Eris; Gurkan Erdogan; Irfan Perente; Gokhan Demir; Burcin Kepez Yildiz; Ebru Demet Aygit
Journal:  Case Rep Ophthalmol Med       Date:  2017-10-02

5.  Alternative management of central serous chorioretinopathy using intravitreal metoprolol.

Authors:  Annelise Nicotti Gonçalves; Ingrid U Scott; Rodrigo Jorge
Journal:  Int J Retina Vitreous       Date:  2022-07-25

6.  The Temporal Topography of Central Serous Chorioretinopathy in the Chinchilla Rabbits Induced by Intravenous Injection of Adrenaline: An in vivo Study.

Authors:  Weiming Yan; Pan Long; Lei Zhang; Meizhu Chen; Zuoming Zhang; Tao Chen
Journal:  Drug Des Devel Ther       Date:  2022-09-23       Impact factor: 4.319

7.  Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.

Authors:  Shota Sawaguchi; Nobuhiro Terao; Naoya Imanaga; Sorako Wakugawa; Tamaki Tamashiro; Yukihide Yamauchi; Hideki Koizumi
Journal:  Ophthalmol Sci       Date:  2022-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.